Narrow-Spectrum Antibacterial Agents—Benefits and Challenges

The number of antibacterial agents in clinical and preclinical development possessing activity against a narrow spectrum of bacterial pathogens is increasing, with many of them being nontraditional products. The key value proposition hinges on sparing antibiotic use and curtailing the emergence of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Alm, Richard A., Lahiri, Sushmita D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400354/
https://www.ncbi.nlm.nih.gov/pubmed/32708925
http://dx.doi.org/10.3390/antibiotics9070418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400354/
https://www.ncbi.nlm.nih.gov/pubmed/32708925
http://dx.doi.org/10.3390/antibiotics9070418

Ejemplares similares